Talbot Financial, LLC Merck & Co., Inc. Transaction History

Talbot Financial, LLC

$1.18 Trillion
Q3 2025

A detailed history of Talbot Financial, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Talbot Financial, LLC holds 154,125 shares of MRK stock, worth $14.3 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares

154,125

Previous 140,976 9.33%

Holding current value

$14.3 Million

Previous $11.2 Billion 15.91%

% of portfolio

1.09%

Previous 1.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 08, 2025	BUY	$77.6 - $87.37 $1.02 Million - $1.15 Million	13,149 Added 9.33%	154,125 $12.9 Billion
Q2 2025 Jul 21, 2025	BUY	$73.47 - $87.12 $2.98 Million - $3.53 Million	40,512 Added 40.32%	140,976 $11.2 Billion
Q1 2025 Apr 09, 2025	BUY	$83.01 - $101.02 $418,204 - $508,938	5,038 Added 5.28%	100,464 $9.02 Billion
Q4 2024 Jan 13, 2025	BUY	$96.31 - $114.76 $376,186 - $448,252	3,906 Added 4.27%	95,426 $9.49 Billion
Q3 2024 Oct 08, 2024	BUY	$111.15 - $128.97 $549,303 - $637,369	4,942 Added 5.71%	91,520 $10.4 Billion

Q2 2024 Jul 11, 2024	BUY	$123.8 - $132.96 $196,346 - $210,874	1,586 Added 1.87%	86,578 $10.7 Billion
Q1 2024 Apr 18, 2024	BUY	$113.24 - $131.95 $81,759 - $95,267	722 Added 0.86%	84,992 $11.2 Billion
Q4 2023 Jan 11, 2024	BUY	$100.18 - $109.02 $464,634 - $505,634	4,638 Added 5.82%	84,270 $9.19 Billion
Q3 2023 Oct 24, 2023	BUY	$102.95 - $114.33 $37,164 - $41,273	361 Added 0.46%	79,632 $8.2 Billion
Q2 2023 Jul 28, 2023	BUY	$108.61 - $118.38 $47,679 - $51,968	439 Added 0.56%	79,271 $9.15 Billion
Q1 2023 May 08, 2023	BUY	$102.94 - $114.86 $102,116 - $113,941	992 Added 1.27%	78,832 $8.39 Billion
Q4 2022 Feb 16, 2023	BUY	$87.44 - $112.11 $6.81 Million - $8.73 Million	77,840 New	77,840 $8.64 Billion

Others Institutions Holding MRK

# of Institutions

3,875

Shares Held

1.9B

Call Options Held

30.1M

Put Options Held

27.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $235B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Talbot Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Talbot Financial, LLC with notifications on news.

Account

Talbot Financial, LLC Merck & Co., Inc. Transaction History